A Prospective Study to Evaluate the Incidence of Skeletal Related Events In Prostate Cancer Patients Undergoing Androgen Deprivation Therapy (ADT).
Phase of Trial: Phase IV
Latest Information Update: 26 Dec 2016
At a glance
- Drugs Goserelin (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Acronyms BHOS
- 21 Dec 2016 Status changed from active, no longer recruiting to completed.
- 31 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 07 Sep 2010 New trial record